Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antioxidants change platelet responses to various stimulating events

A Sobotkova, L Masova-Chrastinova, J Suttnar, J Stikarova, P Majek, Z Reicheltova, R Kotlin, JW Weisel, M Maly, JE Dyr

Jazyk angličtina Země Spojené státy americké

Typ dokumentu Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12008603

Grantová podpora
NS10633 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje

NLK ScienceDirect (archiv) od 1993-01-01 do 2009-12-31

The role of platelets in hemostasis may be influenced by alteration of the platelet redox state-the presence of antioxidants and the formation of reactive oxygen and nitrogen species. We investigated the effects of two antioxidants, resveratrol and trolox, on platelet activation. Trolox and resveratrol inhibited aggregation of washed platelets and platelet-rich plasma activated by ADP, collagen, and thrombin receptor-activating peptide. Resveratrol was a more effective agent in reducing platelet static and dynamic adhesion in comparison with trolox. The antioxidant capacity of resveratrol was, however, the same as that of trolox. After incubation of platelets with antioxidants, the resveratrol intraplatelet concentration was about five times lower than the intracellular concentration of trolox. Although both antioxidants comparably lowered hydroxyl radical and malondialdehyde production in platelets stimulated with collagen, TxB(2) levels were decreased by resveratrol much more effectively than by trolox. Cyclooxygenase 1 was inhibited by resveratrol and not by trolox. Our data indicate that antioxidants, apart from nonspecific redox or radical-quenching mechanisms, inhibit platelet activation also by specific interaction with target proteins. The results also show the importance of studying platelet activation under conditions of real blood flow in contact with reactive surfaces, e.g., using dynamic adhesion experiments.

000      
03589naa a2200541 a 4500
001      
bmc12008603
003      
CZ-PrNML
005      
20200930102610.0
008      
120316s2009 xxu eng||
009      
AR
040    __
$a ABA008 $b cze $d ABA008
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hlaváčková, Alžběta $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic. $7 xx0122087
245    10
$a Antioxidants change platelet responses to various stimulating events / $c A Sobotkova, L Masova-Chrastinova, J Suttnar, J Stikarova, P Majek, Z Reicheltova, R Kotlin, JW Weisel, M Maly, JE Dyr
520    9_
$a The role of platelets in hemostasis may be influenced by alteration of the platelet redox state-the presence of antioxidants and the formation of reactive oxygen and nitrogen species. We investigated the effects of two antioxidants, resveratrol and trolox, on platelet activation. Trolox and resveratrol inhibited aggregation of washed platelets and platelet-rich plasma activated by ADP, collagen, and thrombin receptor-activating peptide. Resveratrol was a more effective agent in reducing platelet static and dynamic adhesion in comparison with trolox. The antioxidant capacity of resveratrol was, however, the same as that of trolox. After incubation of platelets with antioxidants, the resveratrol intraplatelet concentration was about five times lower than the intracellular concentration of trolox. Although both antioxidants comparably lowered hydroxyl radical and malondialdehyde production in platelets stimulated with collagen, TxB(2) levels were decreased by resveratrol much more effectively than by trolox. Cyclooxygenase 1 was inhibited by resveratrol and not by trolox. Our data indicate that antioxidants, apart from nonspecific redox or radical-quenching mechanisms, inhibit platelet activation also by specific interaction with target proteins. The results also show the importance of studying platelet activation under conditions of real blood flow in contact with reactive surfaces, e.g., using dynamic adhesion experiments.
536    __
$c Grant Number: NS10633-3 (United States NINDS NIH HHS)
536    __
$c Grant Number: R01 HL030954-24 (United States NHLBI NIH HHS)
536    __
$c Grant Number: R01 HL090774-03 (United States NHLBI NIH HHS)
590    __
$a bohemika - dle Pubmed
650    02
$a antioxidancia $x farmakologie $7 D000975
650    02
$a trombocyty $x fyziologie $x účinky léků $7 D001792
650    02
$a buněčná adheze $x fyziologie $x účinky léků $7 D002448
650    02
$a kultivované buňky $7 D002478
650    02
$a chromany (dihydrobenzopyrany) $x farmakologie $7 D002839
650    02
$a kolagen $7 D003094
650    02
$a cyklooxygenasa 1 $x metabolismus $7 D051545
650    02
$a hemostáza $x účinky léků $7 D006487
650    02
$a lidé $7 D006801
650    02
$a malondialdehyd $x metabolismus $7 D008315
650    02
$a agregace trombocytů $x fyziologie $x účinky léků $7 D010974
650    02
$a stilbeny $x farmakologie $7 D013267
650    02
$a thromboxan B2 $x metabolismus $7 D013929
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chrastinová, Leona $7 xx0122084
700    1_
$a Suttnar, Jiří, $d 1949- $7 xx0061396
700    1_
$a Stikarova, Jana
700    1_
$a Májek, Pavel $7 xx0128730
700    1_
$a Riedelová, Zuzana $7 xx0126185
700    1_
$a Kotlin, Roman
700    1_
$a Weisel John W.
700    1_
$a Malý, Martin, $d 1966- $7 mzk2004241073
700    1_
$a Dyr, Jan E.
773    0_
$t Free Radical Biology & Medicine $p Free Radic Biol Med $g Roč. 47, č. 12 (2009), s. 1707-1714 $w MED00001857 $x 1210-0668
773    0_
$p Free Radic Biol Med $g 47(12):1707-14, 2009 Dec 15
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20120319124543 $b ABA008
991    __
$a 20200930102607 $b ABA008
999    __
$a ok $b bmc $g 901954 $s 765498
BAS    __
$a 3
BMC    __
$a 2009 $b 47 $c 12 $d 1707-1714 $m Free radical biology & medicine $x MED00001857
GRA    __
$a NS10633 $p MZ0
LZP    __
$a 2012-1Q10/jj

Najít záznam